Evidence map›Paper›PMID 27752055›Full record

ArticleScientific reports2016

Genome-wide diversity and gene expression profiling of Babesia microti isolates identify polymorphic genes that mediate host-pathogen interactions.

Joana C Silva, Emmanuel Cornillot, Carrie McCracken, Sahar Usmani-Brown, Ankit Dwivedi, Olukemi O Ifeonu, Jonathan Crabtree, Hanzel T Gotia, Azan Z Virji, Christelle Reynes and 22 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification ofInfection and immunity · 2024
    Article
  4. Review
  5. Transfusion-transmittedJournal of clinical microbiology · 2023
    Review
  6. Article
  7. Article
  8. Advances inPathogens (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Major Surface Antigens in ZoonoticPathogens (Basel, Switzerland) · 2022
    Review
  15. HarnessingVaccines · 2022
    Review
  16. Article
  17. Article
  18. Technologies for Detection ofPathogens (Basel, Switzerland) · 2021
    Review
  19. In Silico Survey and Characterization ofPathogens (Basel, Switzerland) · 2021
    Article
  20. The Global Emergence of Human Babesiosis.Pathogens (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 5 institutions in 2 countries.

Joana C SilvaInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Emmanuel CornillotInstitut de Biologie Computationnelle, IBC, Université de Montpellier, 860 rue St Priest, Bat 5 - CC05019, 34095 Montpellier, Cedex 5, France.
Carrie McCrackenInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Sahar Usmani-BrownDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, 15 York St., New Haven, Connecticut, CT 06520 USA.
Ankit DwivediInstitut de Biologie Computationnelle, IBC, Université de Montpellier, 860 rue St Priest, Bat 5 - CC05019, 34095 Montpellier, Cedex 5, France.
Olukemi O IfeonuInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Jonathan CrabtreeInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Hanzel T GotiaInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Azan Z VirjiDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, 15 York St., New Haven, Connecticut, CT 06520 USA.
Christelle ReynesInstitut de Genomique Fonctionnelle, IGF - CNRS UMR 5203, 141 rue de la cardonille, 34094 Montpellier, Cedex 05, France.
Jacques ColingeInstitut de Recherche en Cancérologie de Montpellier, IRCM - INSERM U896 &Université de Montpellier &ICM, Institut régional du Cancer Montpellier, Campus Val d'Aurelle, 34298 Montpellier, Cedex 5 France.
Vidya KumarDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, 15 York St., New Haven, Connecticut, CT 06520 USA.
Lauren LawresDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, 15 York St., New Haven, Connecticut, CT 06520 USA.
Joseph E PazziAntigen Discovery Inc., Irvine, CA, 92618 USA.
Jozelyn V PabloAntigen Discovery Inc., Irvine, CA, 92618 USA.
Chris HungAntigen Discovery Inc., Irvine, CA, 92618 USA.
Jana BrancatoYale School of Public Health and Yale School of Medicine, 60 College St., New Haven, Connecticut, CT 06520 USA.
Priti KumariInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Joshua OrvisInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Kyle TretinaInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Marcus ChibucosInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Sandy OttInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Lisa SadzewiczInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Naomi SengamalayInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Amol C ShettyInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Qi SuInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Luke TallonInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Claire M FraserInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore MD 21201 USA.
Roger FrutosUniversité de Montpellier, IES, UMR 5214, 860 rue de St Priest, Bt5, 34095 Montpellier, France.
Douglas M MolinaAntigen Discovery Inc., Irvine, CA, 92618 USA.
Peter J KrauseYale School of Public Health and Yale School of Medicine, 60 College St., New Haven, Connecticut, CT 06520 USA.
Choukri Ben MamounDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, 15 York St., New Haven, Connecticut, CT 06520 USA.
University of Maryland, Baltimore · USYale University · USAntigen Discovery (United States) · USUniversité de Montpellier · FRCentre National de la Recherche Scientifique · FR

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Development of novel therapeutics for Babesia microti infectionR21AI109486 · NIAID · YALE UNIVERSITY · PI BEN MAMOUN, CHOUKRI · 2014 to 2015
$458k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS HHSN272200900009CNIAID NIH HHS R21 AI109486
6 · The paper itself

Abstract

Babesia microti, a tick-transmitted, intraerythrocytic protozoan parasite circulating mainly among small mammals, is the primary cause of human babesiosis. While most cases are transmitted by Ixodes ticks, the disease may also be transmitted through blood transfusion and perinatally. A comprehensive analysis of genome composition, genetic diversity, and gene expression profiling of seven B. microti isolates revealed that genetic variation in isolates from the Northeast United States is almost exclusively associated with genes encoding the surface proteome and secretome of the parasite. Furthermore, we found that polymorphism is restricted to a small number of genes, which are highly expressed during infection. In order to identify pathogen-encoded factors involved in host-parasite interactions, we screened a proteome array comprised of 174 B. microti proteins, including several predicted members of the parasite secretome. Using this immuno-proteomic approach we identified several novel antigens that trigger strong host immune responses during the onset of infection. The genomic and immunological data presented herein provide the first insights into the determinants of B. microti interaction with its mammalian hosts and their relevance for understanding the selective pressures acting on parasite evolution.

Indexed as

Polymorphism, GeneticProteomicsAnimalsBabesia microtiBabesiosisGene Expression RegulationGenome, ProtozoanGenomicsHost-Parasite InteractionsHumansIxodesMicroarray AnalysisNew England

Identifiers

PMID27752055
PMCPMC5082761
OpenAlexW2538844440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.